limitation in PC is the painful and debilitating plantar keratoderma. This pain limits mobility and is worse with continued standing or walking. It endures for hours at the end of the day, and many patients resort to walking on hands and knees when at home. The more labor intensive the work, the greater are the calluses and resultant pain. Some patients are wheelchair restricted, whereas others use walking aids. To date, no specific questionnaire addresses the characteristic features affecting quality of life (QoL) in PC patients. A number of treatments for PC are nearing the clinical trial phase. Treatments reaching this point include simvastatin, which was shown to have an inhibitory effect on the KRT6A promoter, small interfering ribonucleic acid (siRNA), and rapamycin. [2] [3] [4] New assessment measures are being developed to document the efficacy of treatment. These include the use of a treadmill to assess improvement in mobility.
Establishing a clinically and statistically valid measure for PCQoL will be valuable in assessing disease-relevant change during planned future clinical interventions. This index will be used to detect when significant change has occurred and has been based on the Dermatology Life Quality Index (DLQI). 5 
Methods

Question Design and Participants
In 2004, the nonprofit organization Pachyonychia Congenita Project established a registry collecting clinical and genetic data. Initially, the questionnaire used in the registry was developed by a joint patient/physician panel and, in addition to demographics, provided detailed information regarding whether and to what extent patients were affected by described clinical features of PC. In 2006, following the initial experience with 100 patients, the questionnaire was shortened. The PC registry now has 467 genetically confirmed PC patients. In addition, 15 patient support meetings have been held, with 510 PC patients participating. We used the questionnaires and patient interviews to structure questions that were relevant to QoL in patients with PC.
Based on the DLQI, there are 12 questions in the PCQoL (Appendix). The PCQoL is meant as a diseasespecific tool to assess the response of treatment in PC patients. The emphasis is on the physical domain as this is clearly the most significant determinant of QoL in these patients. As in the DLQI, there are four possible answers. Responses for each question were assigned scores as follows: ''not at all'' 5 0, ''a little'' 5 1, ''a lot'' 5 2, ''very much'' 5 3. A few questions had a fifth choice of ''not relevant,'' which was assigned a score of 0.
Patient Selection
The PCQoL questionnaire was administered to PC patients, who were recruited through the Pachyonychia Congenita Project. All participant data included in the analysis were from patients with a confirmed PC keratin mutation. Inclusion criteria were disease duration of at least 6 months, active PC causing self-reported functional impairment, no significant psychiatric comorbidity, no comorbid process with similar effects on QoL, age . 18 years, fluency in English, and ability to provide informed consent. Seventy-six patients participated with the following genetic subtypes of PC: 32 patients with PC-6a, 5 with PC-6b, 2 with PC-6c, 28 with PC-16, and 9 with PC-17.
Ethics Approval
Ethics approval for this study was obtained from University of Saskatchewan Research Ethics Board. The use of the PC registry data was approved by the Western Institutional Review Board (study #20040468).
Statistical Analysis
Traditional analysis based on classical test theory (CTT) and Rasch analysis (RA) were performed to evaluate test-retest reliability, internal consistency reliability, dimensionality, floor and ceiling effects, concurrent validity, and construct validity. Using RA, an item-person map, bubble chart, and category probability curve were generated. CTT analysis was performed using SPSS version 19 (IBM SPSS Statistics, Armonk, NY). RA was performed using Ministep software version 3.73 (Winsteps, Lincare & Wright, Chicago, IL).
A summary of the criteria used is provided in Table 1 .
Results
Classical Test Theory
Test-Retest Reliability
The Table 1 ), confirming the repeatability/reliability of the PCQoL questionnaire. Thus, if a patient's medical status is stable, when the questionnaire is administered at two different time points, the patient's scores should be similar.
Internal Consistency Reliability
The Cronbach a coefficient scores were marginally higher for the PC group than for the control group but within the acceptable range for internal consistency ( Table 2 ). This test determines the internal consistency of responses between questions of the PCQoL for both groups. The column ''a if Item Deleted'' shows the highest achievable value of a that can be obtained when a specific question is dropped and is indicated in brackets in Table 2 . Exclusion of any of the 12 items in either group did not increase a significantly, suggesting that all questions are worthy of retention.
Dimensionality
The validity of exploratory factor analysis (EFA) was verified first by the Bartlett test, which was found to be highly significant (p , .001). 6 The Kaiser-Meyer-Olkin measure of sampling adequacy of 0.82 and 0.78 for PCQoL and DLQI, respectively, exceeds 0.5 in both cases, indicating that factor analysis is appropriate. 7, 8 = Based on the criteria, an eigenvalue above 1.0, a scree plot with a sharp drop in eigenvalues, and items with a factor loading of 0.4 or more (see Table 1 ), three factors were revealed in both the DLQI and the PCQoL. This suggests that both questionnaires are multidimensional.
Floor and Ceiling Effects
These effects are present when respondents believe that their condition (QoL) has improved or deteriorated beyond that which the questionnaire can measure. There were no floor or ceiling effects for factors 1 and 2 in the PCQoL (see Table 1 ). Factor 3 was found to have no ceiling effect; however, some floor effects were noted, suggesting overall good QoL.
Validity
The following types of validity were analyzed for the PCQoL scale.
Concurrent validity A statistically significant strong Spearman correlation of # 0.95 was found between PCQoL first response scores and corresponding DLQI scores in each factor, confirming concurrent validity for the PCQoL. Given that similar scores were reported and the DLQI is a valid dermatologic questionnaire, this validates the PCQoL.
Construct validity All questions in the PCQoL showed the highest correlation ($ 0.40) with factors to which they were assigned than with other factors. [9] [10] [11] This supports construct validity for the three factors determined by EFA.
Item Response Theory: Rasch Model
Model Data Fit
Values of the person and item infit and outfit statistics were found to be within the acceptable range (mean square residual [MNSQ] 0.5 to 1.5; standardized mean square residual [Z-standardized (Zstd)] 22.0 to 2.0) ( Table 3) . 12, 13 The chi-square probability (p , .001) indicates that our questionnaire was measuring a dominant rather than a unidimensional scale. This suggests that patients and questions were both representative of the disease process.
Internal Consistency
The item and person reliability indices were 0.97 and 0.87, respectively, verifying PCQoL as a reliable instrument (see Table 3 ). The person reliability index is an indicator for overall precision. High values suggests that the instrument is well targeted for PC patients. The high item reliability index indicates that the responses to items are consistent. 
Construct Validity
Item-Person Fit
Overall, the item-person ( Figure 1 ) map shows fairly good spread of persons and items along the scale, indicating a good overall match between item difficulties and person abilities. The bubble chart (Figure 2 ) illustrates the fitness of person ability and item difficulty measures simultaneously, along with the magnitude of measurement error. Question 1, located leftmost in the chart, has the most regular answer pattern and is marginally overfit to the model. Greatly and poorly affecting QOL items were found to be questions 8 and 11.
Response Categories Structure
The criteria for differences between response categories hold well for all categories except between categories 2 and 3, which are 0.95 logit apart ( Figure 3 ). 14 Although the Lincare criterion was not fully satisfied, there is no need to reorganize the four rating scales because the average measures and threshold were found to increase monotonically with categories, the probability curve shows an ordered distinct pattern with good transition between all categories, and infit and outfit MNSQ for each category were within the acceptable range.
RA-Based Principal Component Analysis of Residuals
Principal component analysis of residuals (PCAR) identified three domains for the PCQoL. Domain 1 contains questions 1, 2, and 5. Domain 2 contains questions 6, 7, and 8. Domain 3 contains questions 3, 4, 9, 10, 11, and 12. Thus, our questionnaire is multidimensional.
Validity
All questions showed the highest correlations ($ 0.40) with domains to which they were assigned than with other domains. 11 Correlations between an item and the other dimensions were low, confirming convergent and divergent validity. each domain with first contrast eigenvalues of 1.7 or less. 15, 16 Thus, all three Rasch domains satisfy the criteria for unidimensionality.
Discussion
Disease-specific QoL measures are important in focusing attention to those aspects of life that are particularly pertinent to a specific disease. Treatment success is assessed not only by measuring changes in a particular disease state but also how the QoL of the sufferer has improved. Several clinical trials for PC are being considered, and a disease-specific QoL measure has been developed and validated in this study.
Our CTT analysis shows that test-retest reliability for both control and PC groups demonstrated very good reproducibility. Thus, if a patient's clinical condition remains the same and the questionnaire is readministered, a very similar score will be obtained. The Cronbach a test confirmed or validated the internal consistency for the PCQoL. It also suggested that all 12 questions are worthy of retention. Our construct validity finding of three factors is in agreement with our RA findings as well as with other reports. 17 Floor and ceiling effects demonstrated an overall good spread for QoL assessment, indicating that the participant's condition (QoL) did not improve or deteriorate beyond the measurement capacity of the PCQoL. PCQoL scores to the DLQI, measured essentially at the same time. Given that the DLQI is widely used and validated, these associations support PCQoL validity. 18 Construct validity was confirmed because questions correlated highest with the factor to which they belonged.
To overcome several limitations of CTT, modern measurement methods, commonly referred to as ''item response theory'' (IRT), are employed. [19] [20] [21] One of these models, the Rasch measurement model, estimates the ''goodness of fit'' between item difficulty and person ability. 22 Rasch models have been used in the validation of a series of questionnaires and are essential in evaluating measurement tools in specific disease cohorts. 23, 24 Overall, all items of the PCQoL scale fit to the Rasch model very well. The standard deviation for person estimates is slightly larger than the corresponding item estimates, indicating a slightly wider spread within person measures. Internal consistency demonstrated the PCQoL to be a reliable instrument (see Table 3 ). Our item reliability value of 6.24 suggests excellent reproducibility when these patients are given a similar QoL questionnaire. A person separation index of 2.61 indicates that patients have reasonable spread along the scale (ie, are well represented). Our separation index values indicate that PCQoL has good construct validity. Person reliability was lower than item reliability, which may be due to the inherent variability in individualized behaviors specifically in a large sample with few items. 25 Item hierarchy of PCQoL in Figure 1 indicates that question 11 (''Over the past week, how much has your skin caused any sexual difficulties?'') least affects QoL, whereas question 8 (''Over the past week, has the pain in your feet made it difficult for you to do any sport?'') greatly affects QoL (see Figure 1) . Overall, we found that personal relationships were the least affected by PC, whereas leisure activities were affected the most. To ensure appropriate ordering of our scoring system, patterns of multiple response categories were analyzed by category probability graph and Andrich threshold estimates for the transition from one rating scale to another. 26 Our analysis showed an ordered set of response thresholds. There is no evidence of inappropriate use of the scale categories, no underuse categories, and no inversions. The scoring system was found to be reasonably spaced for all items, indicating that the response design, that is, four options for each question, was appropriate (see Figure 3) . Thus, collapsing of response categories is not required.
Factor analysis demonstrated a three-factor structure that broadly corresponds to the three domains determined by PCAR. The difference in item groupings is likely due to different methodologies. Conventional factor analysis identified factors within a correlational matrix, whereas PCAR is based on the existence of the multidimensionality in the residuals.
Our overall analysis supports the PCQoL as a useful measure for assessing QoL in PC patients, particularly those with significant keratoderma. It may not be the most useful tool to assess QoL in PC patients who have KRT17 mutations, where large disfiguring cysts and scarring are prominent. The PCQoL has better validity and responsiveness for QoL changes than the DLQI for PC patients. This study has shown that a brief, direct, intervieweradministered PCQoL questionnaire can provide useful data on the QoL of patients with PC. Recently, Fu and colleagues examined PC genotypes and subsequent physical limitations on a Likert scale. 34 They found that clinical severity depends on the genotype. 27 However, this study is the first to formally create and critique a questionnaire for patients with PC. We hope that our questionnaire will be used as an objective marker for the treatment of PC patients in the clinical setting.
Acknowledgments
We Over the last week, how much has your skin interfered with you going shopping or looking after your home or garden? Q7. Over the past week, how much has the pain in your feet affected any social or leisure activity?
Over the last week, how much has your skin affected any social or leisure activities? Q8. Over the past week, has the pain in your feet made it difficult for you to do any sport?
Over the last week, how much has your skin made it difficult for you to do any sport? Q9. Over the past week, has your PC prevented you from working or studying?
Over the last week, has your skin prevented you from working or studying? If ''No,'' over the past week, how much trouble has your PC been a problem at work or studying?
If ''No,'' over the last week, how much has your skin been a problem at work or studying? Q10. Over the past week, how much has your skin created problems with your close friends or relatives?
Over the last week, how much has your skin created problems with your partner or any of your close friends or relatives? Q11. Over the past week, how much has your PC caused any sexual difficulties?
Over the last week, how much has your skin caused any sexual difficulties? Q12. Over the past week, how much of a problem has it been to take care of your PC?
Over the last week, how much of a problem has the treatment for your skin been, for example, by making your home messy or by taking up time? 
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